The Gateway45m
Parkinson’s disease impacts mental aspects of movement, U of A researchers find
Parkinson’s is a neurodegenerative disorder — a disorder that affects the brain and worsens over time — with no known cure.
AC Immune’s Promising Trial Results for Parkinson’s Therapy
AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...
AC Immune stock jumps 20% on data for Parkinson's disease drug
AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
Nanowerk1d
Nanodiamonds bring new hope for Parkinson's research with advanced neuronal sensing
Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...
manilatimes1d
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...
Neuroscience News2d
Parkinson’s Progression Linked to New Protein Pathway
Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.
I'll go to Switzerland to die if my Parkinson's deteriorates - I don't want to suffer like my mother did, insists defiant John Stapleton in emotional Lorraine interview
The 78-year-old broadcaster lifted the lid on how he has been coping with the health news, as well as sharing his opinion on ...
News Medical2d
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Researchers identify a potential biomarker of Parkinson's disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Pharmaceutical Technology3d
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...
Jewish Press3d
TAU Researchers Discover Potential Target for Effective Parkinson’s Treatments
Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...